Boston Marriott Cambridge, Two Cambridge Ctr & 50 Broadway, Cambridge, MA 02142
March 4-5, 2013
microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways makes them an excellent target for pharmaceutical drug development, and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics. This conference highlights novel developments in using miRNAs for health and disease, and it will discuss novel applications and progress made in manipulating microRNA. Opportunities for using microRNA as a tool will also be explored. 20+ SCIENTIFIC PRESENTATIONS COVERING: - Therapeutic Potential in Inflammation, Cancer and Pain
- New Technological Strategies
- microRNAs as Biomarkers and in Diagnostics
- Tissue-Based Analysis
- Circulating miRNAs
SHORT COURSE: Sunday, March 3 - Computational Aspects of microRNA
AGENDA HIGHLIGHTS: - microRNAs in Diagnostics and Targeting Rheumatic Disease
- Causes and Consequences of microRNA Dysregulation in Cancer
- Pre-Clinical Development of a Tumor Suppressor miRNA
- microRNAs: Novel Target Class for Small Molecule Drug Discovery?
- Circulating miRNAs as Biomarkers: How Far Have We Made It?
- Extracting Contextual microRNA Information for Cancer Diagnostics
|
|